Introduction
Ischemic cardiomyopathy (ICM), often resulting from the narrowing of coronary arteries, is a leading cause of heart failure (HF).
1,2 More than 1 million people suffer heart attacks each year in the USA alone. Multiple genetic and environmental factors have been linked to ICM. 3 However, the molecular events that lead to this disorder remain elusive.
One surprise of the human genome project was that only about 20 000 to 25 000 protein-coding genes exist in our species. Astonishingly, less than 2% of the sequences in the human genome are used for coding proteins. It is now recognized that the majority of the genome is actively transcribed to produce thousands of non-coding transcripts, including long non-coding RNAs (lncRNAs), which are RNAs >200 nt in length that do not encode proteins. The function of lncRNAs in diverse biological processes and diseases has begun to be investigated. 4, 5 Genome-scale profiling has identified numerous lncRNAs in normal and diseased conditions. 5, 6 Recent studies have linked several lncRNAs to cardiovascular development and disease. Braveheart, a novel lncRNA, has been defined to be a critical regulator of cardiovascular commitment from embryonic stem cells (ESCs). 7, 8 Mechanistically, braveheart mediates the epigenetic regulation of cardiac commitment by interacting with SUZ12, a component of the polycomb repressive complex 2 (PRC2). 7, 9 Fendrr, another novel cardiac lncRNA, has been shown to be an essential regulator of heart and body wall development. 8, 10 Most recently, several studies have documented that expression and function of lncRNAs are associated with a variety of cardiovascular conditions. For example, it was reported that angiotensin II induced the expression of lncRNAs in vascular smooth muscle cells. 11 Another study documented dysregulated lncRNAs in infarcted mouse hearts. 12 Interestingly, Yang et al., 13 performed RNA deep sequencing and they identified HF associated lncRNAs in human patients. Together, these studies suggest that lncRNAs participate in cardiac disease pathogenesis. However, these pioneering studies have likely revealed the tip of the iceberg, and it remains largely unknown how lncRNAs participate in human heart disease, including ischemia-induced cardiomyopathy and HF. In order to gain insight into cardiomyopathy-related lncRNAs, in this study we investigated the expression of lncRNAs in heart samples from human patients with ICM. Compared to controls, we found that the expression of lncRNAs is dysregulated in hearts of ICM patients. We performed experiments to verify the regulation of lncRNAs in diseased hearts and, most importantly, linked the function of dysregulated lncRNAs to the TGF-b pathway and the differentiation of cardiac fibroblasts (CF). Our studies therefore identify novel mechanisms by which lncRNAs regulate cardiac function and disease.
Methods

Cardiac tissues, RNA isolation, RNA-seq, and data analyses
Left ventricular myocardial samples of 15 patients with ICM and 15 non-ICM controls were the same as those used in our prior study.
14 Details regarding the signs and symptoms of the ICM patients were reported.
14 RNA was extracted with Trizol (Invitrogen) and depleted of rRNA using the Ribominus kit (Life Technologies). Illumina RNA-seq libraries were prepared using the standard Illumina protocol. Each of the 30 heart samples was used to generate a separate RNA-seq library that was analyzed on one lane of an Illumina GAIIx (36 nt paired-end reads). Data analyses were performed as described. [15] [16] [17] Additional myocardial samples were obtained from HF patients and controls for RNA extraction and qRT-PCR analysis. 18 For overexpression and knockdown of lncRNAs, CF were isolated from adult or neonatal mouse hearts using a previously described procedure. 19 Details of materials and methods are provided in the Supplementary material online.
Study approval and ethical aspects of the study
Experiments of isolation of CF from adult and neonatal mice were approved by the IACUC of Boston Children's Hospital, Boston, MA, USA. All animal experiments were performed conform the NIH guidelines-Guide for the Care and Use of Laboratory Animals. CO 2 was used to sacrifice the adult mice for the isolation of CF. The flow of CO 2 is slow enough not to make a noise or frighten the animals. Slower flow also allows the animals a more gradual induction of unconsciousness and is thus less stressful. Animals were left in the chamber for a sufficient time (4-5 min) so that complete asphyxia has been attained. For neonatal mice, decapitation was used to sacrifice the animals for the isolation of CF. Acquisition and investigation of de-identified myocardial samples was performed under protocols approved by Institutional Review Boards of The University of Sydney, University of Utah, Comenius University, and Boston Children's Hospital. All patients provided written informed consent. The human study was performed conform the declaration of Helsinki.
Results
Systematic determination of the expression of protein-coding genes in ICM
We obtained left ventricular myocardial samples from 30 human patients, 15 with ICM and 15 sex-and age-matched controls without HF as previously described.
14 Total RNA purified from each myocardial sample was depleted of ribosomal RNA, fragmented, and converted into libraries for high throughput sequencing (see Methods). The 30 libraries were sequenced on an Illumina Genome Analyzer IIx, yielding 36 nucleotide reads from each end of cDNA fragments ( Figure 1A and see Supplementary material online, Figure S1 ). Each sample yielded at least 20 million reads (range: 20.77-38.18 million). About 90% of the reads were useable reads that aligned uniquely to the human genome (see Supplementary material online, Table S1 ). We first measured the expression level of protein-coding genes by transcript read density, quantified as reads per kilobase per million mapped reads (RPKM). Overall intragroup correlation coefficients (Pearson) for all pairwise comparisons of mean expression values >1 RPKM were 0.97 6 0.02 (mean 6 SD) in control and 0.97 6 0.03 in ICM. Intergroup correlations between ICM and control likewise showed a high correlation of 0.99 ( Figure 1B) , suggesting that overall the transcriptome is similar between ICM and control hearts. Hierarchical clustering analyses clearly documented differentially expressed genes between ICM and control samples. A total of 1153 genes are differentially expressed in ICM, with 102 down-and 1051 up-regulated genes when compared to controls (P < 0.05) (see Supplementary material online, Figure S2 , Table S2 ). We then applied a more stringent statistical cutoff (P < 0.01) to the profiling in order to avoid potential false positives. As a result, a total of 285 genes were differentially expressed in ICM (15 down-and 270 up-regulated; see Supplementary material online, Figure S3 ). The results of our analysis are consistent with a recently reported similar study. 13 We inspected the expression of signature marker genes that are associated with HF in the two groups. Indeed, many marker genes were found to be differentially expressed. NPPA and NPPB, well-known HF markers, were up-regulated in ICM samples ( Figure 1B, C) . Consistent with previous reports, MYH6, a transcript encoding a key myosin isoform that mediates heart contraction, was down-regulated in ICM ( Figure 1B,  C) . In addition, genes associated with other functions, such as apoptosis (PHLDA1), cell growth (FRZB, SFRP4, SPOCK, CTGF), and cell cycle control (G0S2) were differentially expressed (see Supplementary mate rial online, Figure S2 , Table S2 ), consistent with a previous report on human dilated cardiomyopathy. 20 We performed Gene Ontology (GO) Figure 1D) . Together, these data show the genome-wide dynamics of proteincoding gene expression in human ICM.
The expression of lncRNAs is altered in ICM
We examined the expression of lncRNAs in ICM and control hearts. We used two lncRNA data sources for our analysis: the NONCODE 3.0 non-coding RNA database 21 and the Human Body Map lincRNAs Catalog. 22 Together, a collective lncRNA gene list containing over 30 000 annotated human lncRNA genes was used in this study. 21, 22 All singleexon transcripts as well as any transcripts overlapping RefSeq genes and known protein-coding genes were removed to exclude potential protein-coding genes ( Figure 2A ). To define a stringent set of candidate lncRNAs, transcripts were selected from the catalogue of expressed transcripts if they fulfilled both of the following criteria: (i) >200 bp long and (ii) expression of >0.5 RPKM in the sample (Methods; Figure 2A ). Out of these transcripts, 145 lncRNAs were differentially expressed between ICM and control (multiple testing corrected P-value <0.05; Figure 2B and see Supplementary material online, Figure S4 , Table S3 ). Of these lncRNAs, 37 and 108 were down-and up-regulated, respectively, in ICM. We selected the significance threshold of P < 0.05 for this analysis because we reasoned that a more stringent threshold (e.g. P < 0.01) might lead to loss of some true positive, novel lncRNAs. Comparing these 145 differentially expressed lncRNAs to 679 lncRNAs differentially expressed in ICM patients in an earlier study, 13 we found that 19 were dysregulated in both studies. Genome browser views of representative differentially expressed lncRNAs are shown in Figure 2C .
To validate the RNA-seq results, we next measured the expression of dysregulated lncRNAs by quantitative RT-PCR (qRT-PCR). Total RNA from control (Ctrl, n¼9) and heart failure (HF, n¼11) patient heart samples were used. We first verified an increased expression of cardiomyopathy markers, including ANP, BNP, and fibrosis markers, including Col8a1 and Col1a1, in the hearts of HF patients ( Figure 2D ). qRT-PCR confirmed altered expression of candidate lncRNAs tested ( Figure 2E) . Next, we analysed the sequence conservation of lncRNAs and compared it with that of protein-coding genes. We computed phastCons scores from the exons of lncRNAs and protein-coding genes that were significantly dysregulated in patient hearts (P < 0.05 for lncRNAs and P < 0.01 for protein-coding genes), using 11 primate species plus mouse. As shown in Figure 2F , both lncRNAs and mRNAs are conserved. However, the distribution of protein-coding mRNA phastCons scores was shifted towards higher values compared to lncRNAs ( Figure 2F) . Specifically, phylopCons scoring shows that 80.5% of 145 differentially expressed lncRNAs are conserved, while 92.2% of 285 differentially expressed protein-coding genes are conserved. Our results support the view that, in general, lncRNAs are less conserved than protein-coding genes at the primary sequence level, which is consistent with previous reports, 15, 16 although some lncRNAs do display high primary sequence conservation. lncRNAs frequently regulate their neighbouring genes. To test the hypothesis that levels of differentially expressed lncRNAs are coupled to their neighboiring genes, we analysed the correlation of a gene and its neighbouring coding genes. Comparing differentially expressed lncRNAcoding gene pairs to differentially expressed coding-coding or random coding-coding pairs, we found that lncRNAs were more correlated to their neighbouring coding ( Figure 2G and see Supplementary material online, Table S4 ). Using a Pearson correlation coefficient of greater than 0.5, 24% of lncRNA-coding gene pairs were correlated, compared to 16% for coding-coding gene pairs (P < 0.001, Fisher's exact test).
Functional correlation between lncRNA expression and ICM
Having identified lncRNAs that are differentially expressed between ICM and control groups, we next attempted to infer the function of these lncRNAs. We first created an lncRNA-lncRNA expression correlation coefficient matrix for the 145 lncRNAs that were differentially expressed in ICM hearts ( Figure 3A ). An lncRNA cluster containing 35 up-regulated lncRNAs in the ICM group showed strong positive expression correlation (Figure 3A , boxed; Figure 3B and see Supplementary material online, Figure S5 ), suggesting that they work together and regulate a common biological process or signalling pathway. Importantly, some of the lncRNAs in these clusters are highly conserved across species. We found that the genomic sequences for lncRNAs n379599 and n379519 are highly conserved among mammalian species ( Figure 3C) , consistent with the result of prior analysis ( Figure 2F) . lncRNAs frequently regulate adjacent genes, 23 and our Pearson correlation coefficient analysis indicates that lncRNAs and their cis-mRNAs display strong correlations ( Figure  2G ). Intriguingly, several of these differentially expressed lncRNA genes are located in the genomic loci adjacent to some known important regulators of cardiac disease. For example, n379599 is located less than 1 kb away from the transcriptional start site of the GATA6 gene, a member of the GATA family of transcription factors, which plays a key role in the regulation of cardiogenesis and cardiac hypertrophy 24 ; n379519 is located less than 3 kb away from the transcriptional start site of the CHP1 gene, which encodes a calcineurin homologous protein 25 ( Figure   3D ). It will be interesting to experimentally determine whether the expression and function of these neighbouring lncRNAs and protein coding genes are correlated to participate in the regulation of cardiac gene expression and heart function. Using qRT-PCR assays, we verified that the expression of lncRNAs from the cluster was elevated in the hearts of patients with HF ( Figure 3E) . Together, these analyses indicate that subsets of lncRNAs are associated with common regulatory pathways involving ICM.
The expression of lncRNAs is linked to ECM gene expression and cardiac fibrosis
Little is known about the biological function of lncRNAs. We hypothesized that the expression patterns and functions of lncRNAs and protein-coding genes are correlated. To establish the potential function of lncRNAs that are differentially expressed in ICM, we created a lncRNA-mRNA expression correlation coefficient matrix between 145 differentially expressed (P < 0.05) lncRNAs and 285 differentially expressed (P < 0.01) mRNAs, using the Pearson correlation method as previously reported 15 ( Figure 4A) . Interestingly, 29 out of the 35 lncRNAs (83%) in the cluster defined above showed a strong positive expression correlation with a cluster of 69 protein-coding genes ( Figure  4B and see Supplementary material online, Figure S6 ). Further analysis of functional annotation clustering using Database for Annotation, Visualization and Integrated Discovery (DAVID) indicates that this cluster of 69 protein-coding genes is highly enriched for functional annotations related to signalling of ECM composition and turnover (Enrichment Score: 15.3). Multiple collagen genes, such as COL14A1, COL16A1, COL12A1, COL8A1, and the gene encoding the ECM protein, periostin, were present in this cluster ( Figure 4C and see Supplementary material online, Figure S7 ). Consistent with this observation, we found that the expression of the lncRNAs n379599 and n342359 was increased in ICM hearts ( Figure 4D) , further supporting the view that these lncRNAs may function in the regulation of ECM components and fibrosis. Similarly, we compared the expression of additional lncRNAs of this cluster in a genome browser and confirmed that they are differentially expressed in ICM samples (see Supplementary material online, Figure S8 ). It is well known that the expression of these ECM genes are dramatically increased and closely related to cardiac fibrosis during cardiac remodelling and dilation. 26, 27 Given that the expression of dysregulated lncRNAs is closely correlated with that of ECM genes, we tested the expression of lncRNAs in cardiomyocytes (CM) and CF. We isolated CM and CF from adult mouse hearts. Molecular marker gene expression confirmed that cardiac troponin (cTNT) is enriched in CM, whereas periostin (Postn) expression marks CF ( Figure 4E , left panel). We examined the expression of mouse homologs of human lncRNAs that are highly conserved between the two species, and we found that several lncRNAs, including n384640, n385786, n380433, and n410105, are enriched in CF ( Figure 4E , right panel). These data suggest that lncRNAs participate in the regulation of cardiac fibrosis in ICM. In order to assign potential functions to these dysregulated lncRNAs, we adapted the 'guilt-by-association' analyses, which have been introduced for functional predictions of mammalian lncRNAs. 15, 16, 22, 28 We examined the expression correlation coefficient between individual lncRNAs and a given functional gene set. The 285 differentially expressed protein-coding genes were classified into 30 functional gene sets, using Gene Set Enrichment Analysis (GSEA). These include Extracellular Region, Organ Development, Multicellular Organismal Development, Cellular Protein Metabolic Process, etc. We then generated a heat map of the expression correlation coefficient between the 145 differentially expressed lncRNAs and the above 30 functional gene sets (GSEA terms) ( Figure 4F) . Remarkably, 32 out of 53 lncRNAs (32/53, 60%), which were previously grouped in the cluster, showed very strong positive 
lncRNAs regulate fibrosis and the expression of ECM genes
To test the hypothesis that lncRNAs are directly involved in the regulation of the expression of genes associated with fibrosis, we took both gain-and loss-of function approaches in isolated CF. We chose from above five highly conserved and CF-enriched lncRNAs (n379599, n379519, n384648, n380433, and n410105) and designed two independent siRNAs for each lncRNA and confirmed that these lncRNAs were knocked down efficiently in mouse CF ( Figure 5A ). We performed immunostaining for a-smooth muscle actin (aSMA), which is expressed in activated CF and a hallmark of fibrotic cardiac diseases, 29 comparing lncRNA knockdown to control ( Figure 5B) . Indeed, inhibition of endogenous lncRNAs resulted in a modest yet statistically significant reduction of aSMA expression ( Figure 5B ). Decreased aSMA expression was further confirmed by western blotting analysis and quantification ( Figure 5C ). Furthermore, quantitative real-time PCR demonstrated the lncRNA knockdown reduced expression of fibrosis genes, including collagen 3A1 (COL3A1), collagen 8A1 (COL8A1), and fibronectin (FBN1) ( Figure 5D ). We have also examined the expression of additional genes related to ECM and fibrosis and found that their expression not altered when lncRNAs were knocked down (see Supplementary material online, Figure S10 ) Conversely, we overexpressed these lncRNAs in CF (see Supplementary material online, Figure S11 ). Immunostaining for aSMA Figure 6A ). Western blotting analysis confirmed the above observation ( Figure 6B) . Finally, we performed qRT-PCR analysis of the expression of ECM and fibrosis genes and found that overexpression of lncRNAs enhanced the expression of Col8A1, Col3A1, and FBN1 ( Figure 6C ), but not that of collagen 1A1 (Col1A1), periostin (POSTN) or elastin (ELN) (see Supplementary material online, Figure S12 ). Together, our gain-and loss-of function investigation indicated that lncRNAs are involved in the regulation of fibrosis related genes.
lncRNAs participate in the TGF-beta signalling pathway
We sought to further understand the molecular mechanism by which these lncRNAs regulate cardiac fibrosis and the expression of ECM genes. The TGF-b signalling pathway has been shown essential for fibrosis and related gene expression. 30 We examined the expression levels of several TGF-b downstream targets that are involved in fibrosis and cell migration. We found that the expression of PAI-1, Snai1, and Snai2 was reduced when lncRNAs were inhibited ( Figure 7A ). Next, we examined the expression of Smad2/3, major mediators of the TGF-b signalling pathway. The expression levels of Smad2/3 protein were not altered; however, the levels of phosphorylated Smad2/3 (pSmad2/3) were decreased when lncRNAs were knockdown ( Figure 7B and see Supplementary material online, Figure S13 ). Conversely, we examined the expression of TGF-b targets PAI-1, Snai1, and Snai2 in CF overexpressing lncRNAs and confirmed that lncRNAs induced the expression of these target genes ( Figure 7C ). Consistent with this result, we showed that levels of phosphorylated Smad2/3, but not that of total Smad2/3 protein, were induced by lncRNAs ( Figure 7D and see Supplementary material online, Figure S14 ). It is worthy to note that the changes of the phosphorylated Smad2/3 levels were not enormous yet statistically significant. Together, these data suggest a molecular mechanism by which lncRNAs modulate the expression of ECM genes, at least in part, through regulating the expression and function of the TGF-b signalling pathway and its downstream targets involved in cardiac fibrosis. 
Discussion
In this study, we discovered that the expression of lncRNAs is altered in the hearts of ICM patients, and that the expression of subsets of lncRNAs positively or negatively correlates with differential expression of ECM genes that participate in cardiac fibrosis and HF. Gain-and lossof function investigations further suggest a direct role of lncRNAs in ECM gene expression. lncRNAs have emerged as a novel class of regulators in diverse biological processes. 4, 5 Thousands of lncRNAs have been reported; many of them are expressed in a tissue-specific manner. 5 Our study links the expression of a subset of lncRNAs to heart disease. While this study was in preparation, a similar study was published. In that study, the investigators profiled lncRNA expression from paired non-ischemic and ischemic human failing left ventricles before and after left ventricular assist device (LVAD). 13, 31 The authors suggested that lncRNAs could be used to discriminate failing hearts of different pathologies. Interestingly, another recent study identified a novel circulating lncRNA, LIPCAR, as a molecular marker for HF. 32 Our study, together with these prior reports, indicates that lncRNAs are a novel class of regulators and biomarkers for cardiovascular biology and diseases. RNA-sequencing results of lncRNAs demonstrate that the expression levels of most lncRNAs are substantially lower than those of proteincoding genes in the heart. This observation is consistent with most previous reports. 5 Nevertheless, our overexpression and knockdown experiments in cultured CF indicate that lncRNAs, though expressed at low levels, play an important role in regulating the expression of ECM related genes. We recognized that the overall changes of lncRNAmediated ECM gene expression appeared to be modest, suggesting that lncRNAs may not directly participate in turning on or off gene expression programs like that of transcription factors. The observation that lncRNA expression is associated with fibrosis could be indirect, resulted from an increased fibrosis in diseased hearts. Our studies further suggest that lncRNAs may impact important signalling pathways, such as the TGF-b pathway, in the heart ( Figure 7E ). Although our results showed that lncRNAs could modulate the levels of phosphorylated Smad2/3, at present it remains to be answered about how exactly lncRNAs achieved it and how the specificity is determined. Clearly, future studies will be needed to provide molecular insights into how lncRNAs function in vitro and in vivo. Nonetheless, our studies highlight the potential functional significance of lncRNAs in fundamental biological processes. Recent studies have linked several lncRNAs to cardiovascular disease. ANRIL was identified as a risk factor for coronary disease. 33 Though it is still not fully understood how ANRIL functions, evidence suggests that this lncRNA may participate in the regulation of histone methylation. 34 Another lncRNA, MIAT (myocardial infarction-associated transcript) (or Gomafu/RNCR2) was identified as a risk factor associated with patients with myocardial infarction. 35 However, how MIAT controls the status of myocardial infarction remains largely unknown. In another case, the genetic loci that encode MYH6 and MYH7, the main myosin heavy chain genes in cardiac muscle, appear to produce a non-coding antisense transcript (Myh7-as). Myh7-as transcription may regulate the ratio of Myh6 and Myh7, altering the function of muscle contraction. 36 Intriguingly, a recent report described a cluster of lncRNA transcripts from Myh7 loci, Myheart (Mhrt) in the regulation of pathological hypertrophy and cardiac remodeling. 37, 38 Our current study reveals that the expression of a subset of lncRNAs is associated with fibrosis in the hearts of ICM patients. Future investigations will focus on the in vivo function of these lncRNAs in cardiac function and cardiac disease.
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